The type I interferon signaling pathway is a target for glucocorticoid inhibition

Molecular and Cellular Biology

Volumn 30, Issue 19, 2010, Pages 4564-4574

  Flammer, Jamie R ^a,b   Dobrovolna, Jana ^b   Kennedy, Megan A ^b   Chinenov, Yurii ^b   Glass, Christopher K ^c   Ivashkiv, Lionel B ^a,b   Rogatsky, Inez ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INTERFERON; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; NUCLEAR RECEPTOR COACTIVATOR 2; RNA POLYMERASE; STAT1 PROTEIN; STAT2 PROTEIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; DRUG EFFECT; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DEXAMETHASONE; FIBROBLASTS; GENE EXPRESSION; GLUCOCORTICOIDS; INTERFERON TYPE I; INTERFERON-STIMULATED GENE FACTOR 3, ALPHA SUBUNIT; MACROPHAGES; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 77956703571     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00146-10     Document Type: Article

References (61)

1. Abraham, S. M., T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, J. Tuckermann, J. Saklatvala, and A. R. Clark. 2006. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203:1883-1889.
2. Adelman, K., M. A. Kennedy, S. Nechaev, D. A. Gilchrist, G. W. Muse, Y. Chinenov, and I. Rogatsky. 2009. Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. Proc. Natl. Acad. Sci. U. S. A. 106:18207-18212.
3. Aittomaki, S., M. Pesu, B. Groner, O. A. Janne, J. J. Palvimo, and O. Silvennoinen. 2000. Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J. Immunol. 164:5689-5697. (Pubitemid 30389810)
4. An, J., R. C. Ribeiro, P. Webb, J. A. Gustafsson, P. J. Kushner, J. D. Baxter, and D. C. Leitman. 1999. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc. Natl. Acad. Sci. U. S. A. 96:15161-15166.
5. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, P. K. Gregersen, and T. W. Behrens. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100:2610-2615.
6. Bengtsson, A. A., G. Sturfelt, L. Truedsson, J. Blomberg, G. Alm, H. Vallin, and L. Ronnblom. 2000. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9:664-671.
7. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711-723.
8. Bhandare, R., G. Damera, A. Banerjee, J. R. Flammer, S. Keslacy, I. Rogatsky, R. A. Panettieri, Y. Amrani, and O. Tliba. 2010. Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am. J. Respir. Cell Mol. Biol. 42:9-15.
9. Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D. M. Livingston. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383:344-347.
10. Bianchi, M., C. Meng, and L. B. Ivashkiv. 2000. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc. Natl. Acad. Sci. U. S. A. 97:9573-9578.
11. Bledsoe, R. K., V. G. Montana, T. B. Stanley, C. J. Delves, C. J. Apolito, D. D. McKee, T. G. Consler, D. J. Parks, E. L. Stewart, T. M. Willson, M. H. Lambert, J. T. Moore, K. H. Pearce, and H. E. Xu. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105.
12. Butler, D. M., A. M. Malfait, L. J. Mason, P. J. Warden, G. Kollias, R. N. Maini, M. Feldmann, and F. M. Brennan. 1997. DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J. Immunol. 159:2867-2876.
13. Chandrasekaran, S., A. E. Deffenbaugh, D. A. Ford, E. Bailly, N. Mathias, and D. Skowyra. 2006. Destabilization of binding to cofactors and SCFMet30 is the rate-limiting regulatory step in degradation of polyubiquitinated Met4. Mol. Cell 24:689-699. (Pubitemid 44839216)
14. Chauhan, S., C. H. Leach, S. Kunz, J. W. Bloom, and R. L. Miesfeld. 2003. Glucocorticoid regulation of human eosinophil gene expression. J. Steroid Biochem. Mol. Biol. 84:441-452.
15. Chen, S. L., K. A. Loffler, D. Chen, M. R. Stallcup, and G. E. Muscat. 2002. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. J. Biol. Chem. 277:4324-4333.
16. Chinenov, Y., M. A. Sacta, A. R. Cruz, and I. Rogatsky. 2008. GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression. Proc. Natl. Acad. Sci. U. S. A. 105:20185-20190.
17. Cho, I. J., and S. G. Kim. 2009. A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR. Mol. Endocrinol. 23:86-99.
18. Chu, C. Q., M. Field, M. Feldmann, and R. N. Maini. 1991. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1125-1132.
19. Crow, M. K., and J. Wohlgemuth. 2003. Microarray analysis of gene expression in lupus. Arthritis Res. Ther. 5:279-287.
20. Darimont, B. D., R. L. Wagner, J. W. Apriletti, M. R. Stallcup, P. J. Kushner, J. D. Baxter, R. J. Fletterick, and K. R. Yamamoto. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:3343-3356.
21. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630-1635.
22. De Bosscher, K., and G. Haegeman. 2008. Minireview: latest perspectives on anti-inflammatory actions of glucocorticoids. Mol. Endocrinol. 23:281-291.
23. Dupont, E., K. Huygen, L. Schandene, M. Vandercruys, K. Palfliet, and J. Wybran. 1985. Influence of in vivo immunosuppressive drugs on production of lymphokines. Transplantation 39:143-147. (Pubitemid 15158469)
24. Franchimont, D., J. Galon, M. Gadina, R. Visconti, Y. Zhou, M. Aringer, D. M. Frucht, G. P. Chrousos, and J. J. O'Shea. 2000. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J. Immunol. 164:1768-1774.
25. Gehin, M., M. Mark, C. Dennefeld, A. Dierich, H. Gronemeyer, and P. Chambon. 2002. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell. Biol. 22:5923-5937.
26. Giraud, S., F. Bienvenu, S. Avril, H. Gascan, D. M. Heery, and O. Coqueret. 2002. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J. Biol. Chem. 277:8004-8011.
27. Grandvaux, N., B. R. tenOever, M. J. Servant, and J. Hiscott. 2002. The interferon antiviral response: from viral invasion to evasion. Curr. Opin. Infect. Dis. 15:259-267.
28. Hall, J. M., D. P. McDonnell, and K. S. Korach. 2002. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 16:469-486.
29. Hooks, J. J., H. M. Moutsopoulos, S. A. Geis, N. I. Stahl, J. L. Decker, and A. L. Notkins. 1979. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301:5-8.
30. Kaiser, F., D. Cook, S. Papoutsopoulou, R. Rajsbaum, X. Wu, H. T. Yang, S. Grant, P. Ricciardi-Castagnoli, P. N. Tsichlis, S. C. Ley, and A. O'Garra. 2009. TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells. J. Exp. Med. 206:1863-1871.
31. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
32. Lau, J. F., I. Nusinzon, D. Burakov, L. P. Freedman, and C. M. Horvath. 2003. Role of metazoan mediator proteins in interferon-responsive transcription. Mol. Cell. Biol. 23:620-628.
33. Lau, J. F., J. P. Parisien, and C. M. Horvath. 2000. Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors. Proc. Natl. Acad. Sci. U. S. A. 97:7278-7283.
34. Lechner, J., T. Welte, J. K. Tomasi, P. Bruno, C. Cairns, J. Gustafsson, and W. Doppler. 1997. Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J. Biol. Chem. 272:20954-20960.
35. Lefstin, J. A., and K. R. Yamamoto. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392:885-888.
36. Lerner, L., M. A. Henriksen, X. Zhang, and J. E. Darnell, Jr. 2003. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 17:2564-2577.
37. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3:651-662.
38. Levy, D. E., I. Marie, and A. Prakash. 2003. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 15:52-58.
39. Litterst, C. M., and E. Pfitzner. 2001. Transcriptional activation by STAT6 requires the direct interaction with NCoA-1. J. Biol. Chem. 276:45713-45721.
40. Loniewski, K., Y. Shi, J. Pestka, and N. Parameswaran. 2008. Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. Mol. Immunol. 45:2312-2322.
41. Lowenberg, M., A. P. Verhaar, G. R. van den Brink, and D. W. Hommes. 2007. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol. Med. 13:158-163.
42. Ma, H., H. Hong, S. M. Huang, R. A. Irvine, P. Webb, P. J. Kushner, G. A. Coetzee, and M. R. Stallcup. 1999. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Mol. Cell. Biol. 19:6164-6173.
43. McCoy, C. E., S. Carpenter, E. M. Palsson-McDermott, L. J. Gearing, and L. A. O'Neill. 2008. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation. J. Biol. Chem. 283:14277-14285.
44. Meijsing, S. H., M. A. Pufall, A. Y. So, D. L. Bates, L. Chen, and K. R. Yamamoto. 2009. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324:407-410.
45. Norbiato, G., M. Bevilacqua, T. Vago, and M. Clerici. 1996. Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 81:2601-2606.
46. Ogawa, S., J. Lozach, C. Benner, G. Pascual, R. K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M. G. Rosenfeld, and C. K. Glass. 2005. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122:707-721.
47. Pratt, W. B., Y. Morishima, M. Murphy, and M. Harrell. 2006. Chaperoning of glucocorticoid receptors. Handb. Exp. Pharmacol. 172:111-138.
48. Preble, O. T., R. J. Black, R. M. Friedman, J. H. Klippel, and J. Vilcek. 1982. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 216:429-431.
49. Reily, M. M., C. Pantoja, X. Hu, Y. Chinenov, and I. Rogatsky. 2006. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 25:108-117.
50. Rogatsky, I., H. F. Luecke, D. C. Leitman, and K. R. Yamamoto. 2002. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. U. S. A. 99:16701-16706.
51. Rogatsky, I., K. A. Zarember, and K. R. Yamamoto. 2001. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. 20:6071-6083.
52. Ronnblom, L., and G. V. Alm. 2001. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194:F59-F63.
53. So, A. Y., C. Chaivorapol, E. C. Bolton, H. Li, and K. R. Yamamoto. 2007. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 3:e94.
54. Stocklin, E., M. Wissler, F. Gouilleux, and B. Groner. 1996. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728. (Pubitemid 26360650)
55. Takeda, T., H. Kurachi, T. Yamamoto, Y. Nishio, Y. Nakatsuji, K. Morishige, A. Miyake, and Y. Murata. 1998. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J. Endocrinol. 159:323-330.
56. Wei, X., H. Xu, and D. Kufe. 2006. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol. Cell 21:295-305. (Pubitemid 43099944)
57. Wu, H. Y., Y. Hamamori, J. Xu, S. C. Chang, T. Saluna, M. F. Chang, B. W. O'Malley, and L. Kedes. 2005. Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD. J. Biol. Chem. 280:3129-3137.
58. Wu, R. C., J. Qin, P. Yi, J. Wong, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 2004. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol. Cell 15:937-949.
59. Xu, J., and Q. Li. 2003. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 17:1681-1692.
60. Ytterberg, S. R., and T. J. Schnitzer. 1982. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25:401-406.
61. Zheng, F. F., R. C. Wu, C. L. Smith, and B. W. O'Malley. 2005. Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor. Mol. Cell. Biol. 25:8273-8284.